Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL23R | Q5VWK5 | 17/20 | 0.59 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7103421 | 1.00 | IL23R (0.59) | IL23RUTS2R | |
| SCHEMBL30710492 | 1.00 | IL23R (0.59) | IL23RUTS2R | |
| Acetic Acid SCHEMBL29377757 | 0.99 | IL23R (0.59) | IL23RUTS2R | |
| Acetic Acid SCHEMBL29757019 | 0.99 | IL23R (0.59) | IL23RUTS2R | |
| SCHEMBL31721667 | 0.95 | IL23R (0.58) | IL23RUTS2R | |
| SCHEMBL29550452 | 0.94 | IL23R (0.61) | IL23RUTS2R | |
| SCHEMBL29550921 | 0.94 | IL23R (0.64) | IL23R | |
| SCHEMBL29550887 | 0.94 | IL23R (0.64) | IL23R | |
| SCHEMBL29550903 | 0.94 | IL23R (0.62) | IL23RUTS2R | |
| SCHEMBL29391843 | 0.93 | IL23R (0.65) | IL23RUTS2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250387432-A1 | SSTR-BINDING ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS | H LEE MOFFITT CANCER CT & RES (US) | 2025-12-25 | — | — | US | disclosed |
| WO-2023250272-A2 | SSTR-BINDING BI-SPECIFIC T-CELL ENGAGING MOLECULES | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC. (US) | 2023-12-28 | — | — | WO | disclosed |
| US-20230235067-A1 | SSTR-2 Binding Chimeric Antigen Receptors | UNIVERSITY OF BARI ALDO MORO (IT) | 2023-07-27 | — | — | US | disclosed |
| US-20160339075-A1 | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE SUSTAINED RELEASE OF SOMATOSTATIN ANALOGS | IPSEN PHARMA S.A.S. (FR) | 2016-11-24 | — | — | US | disclosed |
| US-9352012-B2 | Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs | IPSEN PHARMA S.A.S. (FR) | 2016-05-31 | — | — | US | disclosed |
| US-20130079282-A1 | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE SUSTAINED RELEASE OF SOMATOSTATIN ANALOGS | IPSEN PHARMA S.A.S. (FR) | 2013-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230235067-A1 | SSTR-2 Binding Chimeric Antigen Receptors | SSTR2, SCTR, SSTR1 | IL23R 266/4885UTS2R 163/4885 |
| US-20130079282-A1 | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE SUSTAINED RELEASE OF SOMATOSTATIN ANALOGS | SSTR5, SSTR3, SSTR4 | IL23R 454/4885UTS2R 1684/4885 |
| US-20250387432-A1 | SSTR-BINDING ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS | SCTR, SSTR3, SSTR4 | IL23R 47/4885UTS2R 414/4885 |
| US-20160339075-A1 | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE SUSTAINED RELEASE OF SOMATOSTATIN ANALOGS | SSTR5, SSTR4, SSTR3 | IL23R 483/4885UTS2R 847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.